01
Manufacturer engagement
APL reviews the manufacturer’s portfolio, capacity and export intent.
01 · APL in PakistanAbout
Managing the Pakistan export side.
Adeel Pharmaceutical Link is backed by Sahar Group and manages its pharmaceutical sourcing and export activity in Pakistan. Based in Karachi, APL works directly with Pakistani manufacturers, coordinates products and documentation, and moves approved opportunities into the Sahar Group company network.
Manufacturer relationship management
Managing Sahar Group relationships with established pharmaceutical manufacturers in Pakistan.
Product and documentation coordination
Reviewing products, dossiers and export requirements before they move into a destination market process.
Export management for Sahar Group
Coordinating the Pakistan side of pharmaceutical exports with Sahar Group companies and destination partners.
02 · NetworkRegional operating network
APL in Pakistan. Sahar across the region.
Pakistan / Philippines / Singapore / Vietnam
APL manages pharmaceutical sourcing and export coordination in Pakistan for Sahar Group. Sahar is a group of companies established in the Philippines, with company presence in Singapore and Vietnam.
Source marketPakistan
Regional experienceSahar Group markets
03 · How it worksExport process
From manufacturer to the Sahar network.
APL manages the Pakistan side of the export route, from manufacturer engagement and documentation through to coordination with the relevant Sahar Group company or destination partner.
02
Product assessment
APL reviews each product for category fit and commercial potential.
03
Documentation and regulatory review
APL confirms the required dossiers, certificates and regulatory documents.
04
Group market matching
Suitable products are matched with the relevant Sahar Group market or company.
05
Export management
APL coordinates documentation, product movement and commercial terms in Pakistan.
06
Group company coordination
The approved opportunity moves to the relevant Sahar Group company or destination partner.
04 · The groupThe group behind APL
Backed by Sahar Group.
1988
Group established in the Philippines
30+ yrs
International commercial experience
Group
A portfolio of operating companies
3 markets
Philippines, Singapore and Vietnam
Sahar is a group of companies established in the Philippines in 1988. The group manages companies across pharmaceutical importation, distribution, market development and wider commercial sectors, with company presence in Singapore and Vietnam. APL is backed by Sahar Group and manages pharmaceutical sourcing and export coordination from Pakistan.
APL role within the group
Pakistan pharmaceutical export management.
APL manages manufacturer relationships, product sourcing, documentation and export coordination in Pakistan for Sahar Group.
Selected Sahar Group companies
01 · Philippines
Sahar Pharmaceuticals & Distributors
Part of the group’s established pharmaceutical operating base.
Group company02 · Philippines
Bhyria Pharmaceuticals
Part of the Sahar Group company portfolio.
03 · Philippines
Geofman Pharmaceuticals
Part of the Sahar Group company portfolio.
04 · Philippines
Nahal Pharmaceuticals
Part of the Sahar Group company portfolio.
05 · Philippines
Amson Pharmaceuticals
Part of the Sahar Group company portfolio.
06 · Singapore
Deel Pte. Ltd.
Sahar Group company presence in Singapore.
07 · Vietnam
Sahar International Trading Inc.
Sahar Group company presence in Vietnam.
05 · SourcingManufacturer relationships
Pakistan’s pharmaceutical base.
APL manages Sahar Group’s relationships with pharmaceutical manufacturers in Pakistan. The companies shown represent the manufacturing base APL works across, with products and export opportunities handled on a product-by-product basis.
Geofman Pharma
Logos are shown for identification of the manufacturing base and do not imply endorsement.
06 · LeadershipFounder
Founder & Chairman
Muhammad Ateeque
Dhedhi Bhyria
A Pakistani-Filipino businessman who has spent more than three decades building and managing the Sahar Group of companies across the Philippines and the wider region. APL is backed by that group experience and relationship base.
1988Sahar established in the Philippines
30+ yearsInternational business experience across the region
PakistanAPL manages pharmaceutical sourcing and export coordination for Sahar Group
Regional relationships built over decades.
The founder’s long-standing business and civic presence in the Philippines, the foundation of the relationships APL now builds on.
07 · FAQFor manufacturers
Questions manufacturers ask.
Context for Pakistani manufacturers and international partners considering APL.
01What does APL do?
APL manages pharmaceutical manufacturer relationships, product sourcing, documentation and export coordination in Pakistan for Sahar Group.
02Which manufacturers can work with APL?
Established Pakistani pharmaceutical manufacturers with export-ready products and the documentation to support registration in international markets.
03What is Sahar Group?
Sahar is a group of companies established in the Philippines in 1988. It manages businesses including pharmaceutical companies and has company presence in Singapore and Vietnam.
04How is APL connected to Sahar Group?
APL is backed by Sahar Group and operates as its pharmaceutical sourcing and export management function in Pakistan.
05Does APL manufacture medicines?
No. APL works with Pakistani manufacturers and manages the export process in coordination with Sahar Group companies and destination partners.
06What information should a manufacturer provide?
Product details, category and dosage form, manufacturing information, available registration documentation, existing export history and the markets of interest.
07Who manages registration and regulatory requirements?
Responsibilities depend on the product and destination market. APL confirms the required documentation and coordination responsibilities with the manufacturer and the relevant Sahar Group company or destination partner during the review.
08Does every product qualify for every market?
No. Suitability depends on the product, its documentation and each market’s regulatory and commercial requirements.